title: Resident rounds. Part III: Neutrophilic eccrine hidradenitis in the setting of acute myelogenous leukemia treated with cytarabine.
authors.affiliation: Department of Dermatology, Tulane University School of Medicine, New Orleans, LA, USA.
authors.forename: Darya
authors.initials: D
authors.lastname: Shlapak
authors.forename: Kathyrn
authors.initials: K
authors.lastname: Kerisit
authors.forename: Christine
authors.initials: C
authors.lastname: Lin
authors.forename: Alun
authors.initials: A
authors.lastname: Wang
authors.forename: Brittany
authors.initials: B
authors.lastname: Stumpf
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use*; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D016575:Hidradenitis / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy*; D008875:Middle Aged; D020556:Neutrophil Infiltration / Q000502:physiology; D012867:Skin / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine